Results 11 to 20 of about 12,423 (196)
Energies, 2020 Oily brine from the gas and oil industries remains the most difficult wastewater to treat due to its complex chemical composition, which includes aromatic hydrocarbons.
Ewa Knapik +4 more
doaj +1 more source
Toxins, 2021 In this study, Karenia brevis 165 (K. brevis 165), a Chinese strain, was used to research brevetoxin (BTX) metabolites. The sample pretreatment method for the enrichment of BTX metabolites in an algal culture medium was improved here.
Huihui Shen +6 more
doaj +1 more source
Toxina botunílica tipo B no manejo de distonia não-responsiva a toxina botunílica tipo A [PDF]
Arquivos de Neuro-Psiquiatria, 2003 Injeção de toxina botulínica (BTX) é o tratamento de escolha para distonias focais. Contudo, 10% ou mais dos pacientes que recebem injeções repetitivas de BTX tipo A (BTX-A) perdem resposta (não-respondedores secundários).
Francisco Cardoso
doaj +1 more source
Evaluation of botulinum toxin therapy for chronic anal fissure
Journal of Medicine in Scientific Research, 2018 Background Chronic anal fissure causes severe anal pain that dramatically impairs patient's quality of life. Despite a poorly understood etiology, anal fissures are characterized by continuous spasms of the internal anal sphincter.
Amr Abu El-Ella +2 more
doaj +1 more source
The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction [PDF]
International Neurourology Journal, 2023 Purpose We investigated the effectiveness of intravesical botulinum toxin-A (BTX-A) injection therapy in patients with lower urinary tract dysfunction (LUTD) and upper urinary tract (UUT) deterioration and evaluated whether BTX-A injection therapy could ...
Xuesheng Wang, Zhonghan Zhou, Limin Liao
doaj +1 more source
Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies
Toxins, 2020 Botulinum toxin A (BTX-A) is a powerful neurotoxin with long-lasting activity that blocks muscle contractions. In addition to effects on neuromuscular junctions, BTX-A also plays a role in sensory feedback loops, suggesting the potentiality for pain ...
Ting-Chun Yeh +3 more
doaj +1 more source
BMC Musculoskeletal Disorders, 2017 Background Botulinum toxin A (BTX-A) has been used to reduce spasticity in children with cerebral palsy (CP) for decades. The purpose of this study was to analyze to what extent BTX-A treatment was used to treat spasticity in a total population of ...
Maria Franzén +2 more
doaj +1 more source
Cell & Bioscience, 2020 Background Botulinum toxin type A (BTX-A) was considered to be a new potential drug for neuropathic pain (NP) treatment. Results In vivo, BTX-A attenuated chronic compression injury (CCI)-induced pain in rats, and reduced production of pro-inflammatory ...
Xuan Wang +7 more
doaj +1 more source
Renal Failure, 2019 The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity.
Shang-Jun Wu +6 more
doaj +1 more source
Libyan Journal of Medicine, 2019 Stroke is the second leading cause of mortality worldwide and one of the main causes of adult disability. Many studies have suggested that combination therapies provide better outcomes in patients with stroke than monotherapies.
Mohammad Nasb +4 more
doaj +1 more source